A guardian angel: The involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence

Clinical Science

Volumn 99, Issue 2, 2000, Pages 93-104

  Hildebrandt, Martin ^a   Reutter, Werner ^a   Arck, Petra ^a   Rose, Matthias ^a   Klapp, Burghard F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Dipeptidyl peptidase IV; Nutrition; Peptide hormone metabolism; Psychiatric disorders

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; PEPTIDE HORMONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNE DISEASE; CELL ADHESION; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HORMONE METABOLISM; HUMAN; IMMUNE RESPONSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0033853381     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0990093     Document Type: Review

References (128)

1. 1 Yaron, A. and Naider, F. (1993) Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28, 31-81
2. 2 Mrazkova, O., Grim, M. and Carlson, B. M. (1986) Enzymatic heterogeneity of the capillary bed of rat skeletal muscles. Am. J. Anat. 177, 141-148
3. 3 Elovson, J. (1980) Biogenesis of plasma membrane glycoproteins. Tracer kinetic study of two rat liver plasma membrane glycoproteins in vivo. J. Biol. Chem. 255, 5816-5825
4. 4 Kreisel, W., Reutter, W. and Gerok, W. (1984) Modification of the intramolecular turnover of terminal carbohydrates of dipeptidylaminopeptidase IV isolated from rat-liver plasma membrane during liver regeneration. Eur. J. Biochem. 138, 435-438
5. 5 Darmoul, D., Voisin, T., Couvineau, A. et al. (1994) Regional expression of epithelial dipeptidyl peptidase IV in the human intestines. Biochem. Biophys. Res. Commun. 203, 1224-1229
6. 6 Kozakova, H., Stepankova, R., Kolinska, J. et al. (1998) Brush border enzyme activities in the small intestine after long-term gliadin feeding in animal models of human coeliac disease. Folia Microbiol. Praha 43, 497-500
7. 7 Barth, A., Schulz, H. and Neubert, K. (1974) Untersuchungen und Charakterisierung der Dipeptidylpeptidase IV. Acta Biol. Med. Ger. 32, 157-174
8. 8 Imai, K., Maeda, M., Fujiwara, H. et al. (1992) Dipeptidyl peptidase IV as a differentiation marker of the human endometrial glandular cells. Hum. Reprod. 7, 1189-1194
9. 9 Ruiz, P., Zacharievich, N., Hao, L., Viciana, A. L. and Shenkin, M. (1998) Human thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny. Clin. Immunol. Immunopathol. 88, 156-168
10. 10 Darmoul, D., Lacasa, M., Baricault, L. et al. (1992) Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J. Biol. Chem. 267, 4824-4833
11. 11 Kennett, C. N., Cox, S. W. and Eley, B. M. (1996) Histochemical and immunocytochemical localization of dipeptidyl peptidases II and IV in human gingiva. J. Periodontol. 67, 846-852
12. 12 Suzuki, Y., Erickson, R. H., Sedlmayer, A., Chang, S. K., Ikehara, Y. and Kim, Y. S. (1993) Dietary regulation of rat intestinal angiotensin-converting enzyme and dipeptidyl peptidase IV. Am. J. Physiol. 264, G1153-G1159
13. 13 Stefanovic, V., Ardaillou, N., Vlahovic, P., Placier, S., Ronco, P. and Ardaillou, R. (1993) Interferon-gamma induces dipeptidylpeptidase IV expression in human glomerular epithelial cells. Immunology 80, 465-470
14. 14 Schmitz, T., Underwood, R., Khiroya, R., Bachovchin, W. W. and Huber, B. T. (1996) Potentiation of the immune response in HIV-1 + individuals. J. Clin. Invest 97, 1545-1549
15. 15 Dang, N. H., Torimoto, Y., Shimamura, K. et al. (1991) 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J. Immunol. 147, 2825-2832
16. 16 Plana, M., Vinas, O., De la Calle Martin, O. et al. (1991) Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody. Eur. J. Immunol. 21, 1085-1088
17. 17 Hopsu-Havu, V. K. and Glenner, G. G. (1966) A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide. Histochemie 7, 197-200
18. 18 Kreisel, W., Hildebrandt, H., Mossner, W., Tauber, R. and Reutter, W. (1993) Oligosaccharide reprocessing and recycling of a cell surface glycoprotein in cultured rat hepatocytes. Biol. Chem. Hoppe Seyler 374, 255-263
19. 19 Yamashita, K., Tachibana, Y., Matsuda, Y., Katunuma, N., Kochibe, N. and Kobata, A. (1988) Comparative studies of the sugar chains of aminopeptidase N and dipeptidylpeptidase IV purified from rat kidney brush border membrane. Biochemistry 27, 5565-5573
20. 20 Hartel Schenk, S., Minnifield, N., Reutter, W., Hanski, C., Bauer, C. and Morre, D. J. (1991) Distribution of glycosyltransferases among Golgi apparatus subfractions from liver and hepatomas of the rat. Biochim. Biophys. Acta 1115, 108-122
21. 21 Decaens, C., Rodriguez, P., Bouchaud, C. and Cassio, D. (1996) Establishment of hepatic cell polarity in the rat hepatoma-human fibroblast hybrid WIF-B9. A biphasic phenomenon going from a simple epithelial polarized phenotype to an hepatic polarized one. J. Cell Sci. 109, 1623-1635
22. 22 Hildebrandt, M., Reutter, W. and Gitlin, J. D. (1991) Tissue-specific regulation of dipeptidyl peptidase IV expression during development. Biochem. J. 277, 331-334
23. 23 Hanski, C., Huhle, T., Gossrau, R. and Reutter, W. (1988) Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Exp. Cell Res. 178, 64-72
24. 24 Bednarczyk, J. L., Carroll, S. M., Marin, C. and McIntyre, B. W. (1991) Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation. J. Cell. Biochem. 46, 206-218
25. 25 Campbell, R. M., Stricker, P., Miller, R. et al. (1994) Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences. Peptides 15, 489-495
26. 26 Kieffer, T. J., McIntosh, C. H. and Pederson, R. A. (1995) Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136, 3585-3596
27. 27 Mentlein, R. (1999) Dipeptidyl-peptidase IV (CD26) - role in the inactivation of regulatory peptides. Regul. Pept. 85, 9-24
28. 28 Pesquero, J. B., Jubilut, G. N., Lindsey, C. J. and Paiva, A. C. (1992) Bradykinin metabolism pathway in the rat pulmonary circulation. J. Hypertens. 10, 1471-1478
29. 29 Mentlein, R. and Roos, T. (1996) Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides 17, 709-720
30. 30 Reference deleted
31. 31 Bai, J. P. and Chang, L. L. (1995) The involvement of dipeptidyl peptidase IV in brush-border degradation of GRF(1-29)NH2 by intestinal mucosal cells. J. Pharm. Pharmacol. 47, 698-701
32. 32 Deacon, C. F., Hughes, T. E. and Holst, J. J. (1998) Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes 47, 764-769
33. 33 Drucker, D. J., Shi, Q., Crivici, A. et al. (1997) Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat. Biotechnol. 15, 673-677
34. 34 Heymann, E., Mentlein, R., Nausch, J., Erlanson-Albertson, C., Yoshimoto, T. and Feller, A. C. (1986) Processing of procolipase and trypsinogen by pancreatic dipeptidyl peptidase IV. Biomed. Biochim. Acta 45, 575-584
35. 35 Heymann, E. and Mentlein, R. (1984) Beeinflusst Dipeptidylpeptidase IV Blutdruck und Blutgerinnung? Klin. Wochenschr. 61, 2-10
36. 36 Bueno, L., Fargeas, M. J., Fioramonti, J. and Menezo, Y. (1986) A tetrapeptide isolated from hamster embryo with central opiate properties on gastrointestinal motility but not on pain perception. Life Sci. 39, 141-146
37. 37 Bouras, M., Huneau, J. F. and Tome, D. (1996) The inhibition of intestinal dipeptidylaminopeptidase-IV promotes the absorption of enterostatin and des-arginine-enterostatin across rat jejunum in vitro. Life Sci. 59, 2147-2155
38. 38 Bouras, M., Huneau, J. F., Luengo, C., Erlanson Albertsson, C. and Tome, D. (1995) Metabolism of enterostatin in rat intestine, brain membranes, and serum: differential involvement of proline-specific peptidases. Peptides 16, 399-405
39. 39 Nausch, I., Mentlein, R. and Heymann, E. (1990) The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta. Biol. Chem. Hoppe Seyler 371, 1113-1118
40. 40 Wrenger, S., Kähne, T., Bohuon, C., Weglohner, W., Ansorge, S. and Reinhold, D. (2000) Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). FEBS Lett. 466, 155-159
41. 41 De Meester, I., Korom, S., Van Damme, J. and Scharpe, S. (1999) CD26, let it cut or cut it down. Immunol. Today 20, 367-375
42. 42 Augustyns, K., Bal, G., Thomas, G. et al. (1999) The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors. Curr. Med. Chem. 6, 311-327
43. 43 Morimoto, C. and Schlossman, S. F. (1998) The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161, 55-70
44. 44 Dong, R. P. and Morimoto, C. (1996) Role of CD26 for CD4 memory T cell function and activation. Hum. Cell 9, 153-162
45. 45 Masuyama, J., Berman, J. S., Cruikshank, W. W., Morimoto, C. and Center, D. M. (1992) Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J. Immunol. 148, 1367-1374
46. 46 Masuyama, J., Yoshio, T., Suzuki, K. et al. (1999) Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi) T cells after tight adhesion to human umbilical vein endothelial cell monolayers. J. Exp. Med. 189, 979-990
47. 47 Marguet, D., Bernard, A. M., Vivier, I., Darmoul, D., Naquet, P. and Pierres, M. (1992) cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases. J. Biol. Chem. 267, 2200-2208
48. 48 von Bonin, A., Steeg, C., Mittrucker, H. W. and Fleischer, B. (1997) The T-cell receptor associated zeta-chain is required but not sufficient for CD26 (dipeptidylpeptidase IV) mediated signaling. Immunol. Lett. 55, 179-182
49. 49 von Bonin, A., Huhn, J. and Fleischer, B. (1998) Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol. Rev. 161, 43-53
50. 50 Kähne, T., Lendeckel, U., Wrenger, S., Neubert, K., Ansorge, S. and Reinhold, D. (1999) Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth. Int. J. Mol. Med. 4, 3-15
51. 51 Willheim, M., Ebner, C., Baier, K. et al. (1997) Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J. Allergy Clin. Immunol. 100, 348-355
52. 52 Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S. F. and Morimoto, C. (1993) The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl. Acad. Sci. U.S.A. 90, 4586-4590
53. 53 Steeg, C., Hartwig, U. and Fleischer, B. (1995) Unchanged signaling capacity of mutant CD26/dipeptidylpeptidase IV molecules devoid of enzymatic activity. Cell. Immunol. 164, 311-315
54. 54 Blanco, J., Marie, I., Callebaut, C., Jacotot, E., Krust, B. and Hovanessian, A. G. (1996) Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26. Exp. Cell Res. 225, 102-111
55. 55 Franco, R., Valenzuela, A., Lluis, C. and Blanco, J. (1998) Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol. Rev. 161, 27-42
56. 56 Bauvois, B., Sanceau, J. and Wietzerbin, J. (1992) Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-alpha. Eur. J. Immunol. 22, 923-930
57. 57 Durum, S. K., Schmidt, J. A. and Oppenheim, J. J. (1985) Interleukin 1 : an immunological perspective. Annu. Rev. Immunol. 3, 263-287
58. 58 Beutler, B., Greenwald, D., Hulmes, J. D. et al. (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature (London) 316, 552-554
59. 59 Laouarm, A., Wietzerbin, J. and Bauvois, B. (1993) Divergent regulation of cell surface protease expression in HL-60 cells differentiated into macrophages with granulocyte macrophage colony stimulating factor or neutrophils with retinoic acid. Int. Immunol. 5, 965-973
60. 60 Proost, P., Struyf, S., Schols, D. et al. (1998) Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1 alpha. FEBS Lett. 432, 1-2
61. 61 Ansorge, S., Bühling, F., Hoffmann, T., Kähne, T., Neubert, K. and Reinhold, D. (1995) DP IV/CD26 on human lymphocytes: functional roles in cell growth and cytokine regulation. In Dipeptidyl Peptidase IV (CD26) in Metabolism and the Immune Response (Fleischer, B., ed.), pp. 163-184, Springer Verlag, Berlin
62. 62 Struyf, S., Proost, P., Schols, D. et al. (1999) CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J. Immunol. 162, 4903-4909
63. 63 Oravecz, T., Pall, M., Roderiquez, G. et al. (1997) Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186, 1865-1872
64. 64 Van Coillie, E., Proost, P., Van Aelst, I. et al. (1998) Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37, 12672-12680
65. 65 Iwata, S., Yamaguchi, N., Munakata, Y. et al. (1999) CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. Int. Immunol. 11, 417-426
66. 66 Korom, S., De Meester, I., Onodera, K. et al. (1997) The effects of CD26/DPP IV-targeted therapy on acute allograft rejection. Transplant. Proc. 29, 1274-1275
67. 67 Stancikova, M., Lojda, Z., Lukac, J. and Ruzickova, M. (1992) Dipeptidyl peptidase IV in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 10, 381-385
68. 68 Hagihara, M., Fujiwara, M. and Nagatsu, T. (1989) Activities of dipeptidyl peptidases in BXSB mice and MRL/lpr mice with lupus erythematosus-like syndrome. Biochem. Med. Metab. Biol. 42, 224-231
69. 69 Kamori, M., Hagihara, M., Nagatsu, T., Iwata, H. and Miura, T. (1991) Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis. Biochem. Med. Metab. Biol. 45, 154-160
70. 70 Tanaka, S., Murakami, T., Horikawa, H., Sugiura, M., Kawashima, K. and Sugita, T. (1997) Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int. J. Immunopharmacol. 19, 15-24
71. 71 Tanaka, S., Murakami, T., Nonaka, N., Ohnuki, T., Yamada, M. and Sugita, T. (1998) Anti-arthritic effects of the novel dipeptidyl peptidase IV inhibitors TMC-2A and TSL-225. Immunopharmacology 40, 21-26
72. 72 Gonzalez Gronow, M., Weber, M. R., Gawdi, G. and Pizzo, S. V. (1998) Dipeptidyl peptidase IV (CD26) is a receptor for streptokinase on rheumatoid synovial fibroblasts. Fibrinolysis Proteolysis 12, 129-135
73. 73 Hanski, C., Huhle, T. and Reutter, W. (1985) Involvement of dipeptidylpeptidase IV in fibronectin-mediated adhesion on collagen. Biol. Chem. Hoppe-Seyler 366, 1169-1176
74. 74 Piazza, G. A., Callanan, H. M., Mowery, J. and Hixson, D. C. (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem. J. 262, 327-334
75. 75 Jacotot, E., Callebaut, C., Blanco, J., Riviere, Y., Krust, B. and Hovanessian, A. G. (1996) HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4(+) T cells. Virology 223, 318-330
76. 76 Fleischer, B. (1994) CD26: a surface protease involved in T-cell activation. Immunol. Today 15, 180-184
77. 77 Morimoto, C., Lord, C. I., Zhang, C., Duke Cohan, J. S., Letvin, N. L. and Schlossman, S. F. (1994) Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 91, 9960-9964
78. 78 Vanham, G., Kestens, L., De Meester, I. et al. (1993) Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. J. Acquired Immune Defic. Syndr. 6, 749-757
79. 79 Korom, S., De Meester, I., Stadlbauer, T. H. et al. (1997) Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 63, 1495-1500
80. 80 Mentlein, R., Staves, R., Rix-Matzen, H. and Tinneberg, H. R. (1991) Influence of pregnancy on dipeptidyl peptidase IV activity (CD 26 leukocyte differentiation antigen) of circulating lymphocytes. Eur. J. Clin. Chem. Clin. Biochem. 29, 477-480
81. 81 Maes, M., De Meester, I., Vanhoof, G. et al. (1991) Decreased serum dipeptidyl peptidase IV activity in major depression. Biol. Psychiatry 30, 577-586
82. 82 Maes, M., De Meester, I., Scharpe, S., Desnyder, R., Ranjan, R. and Meltzer, H. Y. (1996) Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Acta Psychiatr. Scand. 93, 1-8
83. 83 Maes, M., Libbrecht, I., Van Hunsel, F. et al. (1998) Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia. Psychol. Med. 28, 957-965
84. 84 Hildebrandt, M., Rose, M., Mayr, C. et al. (1999) Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Scand. J. Immunol. 50, 536-541
85. 85 Myers, R. D. (1994) Neuroactive peptides: unique phases in research on mammalian brain over three decades. Peptides 15, 367-381
86. 86 Zadina, J. E., Hackler, L., Ge, L. J. and Kastin, A. J. (1997) A potent and selective endogenous agonist for the μ-opiate receptor. Nature (London) 386, 499-502
87. 87 Lin, L., Umahara, M., York, D. A. and Bray, G. A. (1998) Beta-casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides 19, 325-331
88. 88 Blass, E. M. and Blom, J. (1996) beta-Casomorphin causes hypoalgesia in 10-day-old rats: evidence for central mediation. Pediatr. Res. 39, 199-203
89. 89 Grandt, D., Dahms, P., Schimiczek, M., Eysselein, V. E., Reeve, Jr, J. R. and Mentlein, R. (1993) Proteolytic processing by dipeptidyl aminopeptidase IV generates receptor selectivity for peptide YY (PYY). Med. Klin. 88, 143-145
90. 90 Qureshi, N. U., Dayao, E. K., Shirali, S., Zukowska-Grojec, Z. and Hauser, G. J. (1998) Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock. Regul. Pept. 75-76, 215-220
91. 91 Püschel, G., Mentlein, R. and Heymann, E. (1982) Isolation and characterization of dipeptidyl peptidase IV from human placenta. Eur. J. Biochem. 126, 359-365
92. 92 Dally, P. (1969) Anorexia Nervosa, William Heinemann Medical Books Ltd, London
93. 93 Maes, M., Goossens, F., Lin, A., De Meester, I., Van Gastel, A. and Scharpe, S. (1998) Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety. Psychoneuroendocrinology 23, 485-495
94. 94 Cunningham, D. F. and O'Connor, B. (1998) A study of prolyl endopeptidase in bovine serum and its relevance to the tissue enzyme. Int. J. Biochem. Cell. Biol. 30, 99-114
95. 95 Pederson, R. A., Kieffer, T. J., Pauly, R., Kofod, H., Kwong, J. and McIntosh, C. H. (1996) The enteroinsular axis in dipeptidyl peptidase IV-negative rats. Metab. Clin. Exp. 45, 1335-1341
96. 96 Holst, J.J. and Deacon, C. F. (1998) Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. Diabetes 47, 1663-1670
97. 97 Tiruppathi, C., Miyamoto, Y., Ganapathy, V. and Leibach, F. H. (1993) Genetic evidence for role of DPP IV in intestinal hydrolysis and assimilation of prolyl peptides. Am. J. Physiol. 265, 81-89
98. 98 Karydis, I. and Tolis, G. (1998) Orexis, anorexia, and thyrotropin-releasing hormone. Thyroid 8, 947-950
99. 99 Chance, W. T. and Fischer, J. E. (1993) Neurotransmitters and food intake (editorial). Nutrition 9, 470-471
100. 100 Bray, G. A. (1993) The nutrient balance hypothesis: peptides, sympathetic activity, and food intake. Ann. N.Y. Acad. Sci. 676, 223-241
101. 101 Xu, B., Kalra, P. S., Moldawer, L. L. and Kalra, S. P. (1998) Increased appetite augments hypothalamic NPY Y1 receptor gene expression: effects of anorexigenic ciliary neurotropic factor. Regul. Pept. 75-76, 391-395
102. 102 Nichol, K. A., Morey, A., Couzens, M. H., Shine, J., Herzog, H. and Cunningham, A. M. (1999) Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control. J. Neurosci. 19, 10295-10304
103. 103 Chen, C. H., Stephens, Jr, R. L. and Rogers, R. C. (1997) PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol. Motil. 9, 109-116
104. 104 Iwaki Egawa, S., Watanabe, Y., Kikuya, Y. and Fujimoto, Y. (1998) Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. J. Biochem. (Tokyo) 124, 428-433
105. 105 Wilson, M. J., Ruhland, A. R., Pryor, J. L. et al. (1998) Prostate specific origin of dipeptidylpeptidase IV (CD-26) in human seminal plasma. J. Urol. 160, 1905-1909
106. 106 Abbott, C. A., Gorrell, M. D., Kobayashi, Y. et al. (1995) Increased serum levels of dipeptidyl peptidase IV (CD26) in rats undergoing liver regeneration. Int. Hepatol. Commun. 4, 165-174
107. 107 Juillerat Jeanneret, L., Aubert, J. D. and Leuenberger, P. (1997) Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme). J. Lab. Clin. Med. 130, 603-614
108. 108 Uematsu, T., Urade, M., Yamaoka, M. and Yoshioka, W. (1996) Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. J. Oral Pathol. Med. 25, 507-512
109. 109 Hanski, C., Zimmer, T., Gossrau, R. and Reutter, W. (1986) Increased activity of dipeptidyl peptidase IV in serum of hepatoma-bearing rats coincides with the loss of the enzyme from the hepatoma plasma membrane. Experientia 42, 826-828
110. 110 Maes, M., Scharpe, S., De Meester, I. et al. (1994) Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects. Clin. Chem. 40, 1686-1691
111. 111 Larsson, L. I. and Rehfeld, J. F. (1978) Distribution of gastrin and CCK cells in the rat gastrointestinal tract. Evidence for the occurrence of three distinct cell types storing COOH-terminal gastrin immunoreactivity. Histochemistry 58, 23-31
112. 112 Medeiros, M. S. and Turner, A. J. (1994) Post-secretory processing of regulatory peptides: the pancreatic polypeptide family as a model example. Biochimie 76, 283-287
113. 113 Hackler, L., Kastin, A. J. and Zadina, J. E. (1994) Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2). Peptides 15, 945-950
114. 114 Chang, K. J., Lillian, A., Hazum, E., Cuatrecasas, P. and Chang, J. K. (1981) Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors. Science 212, 75-77
115. 115 Conlon, J. M. and Sheehan, L. (1983) Conversion of substance P to C-terminal fragments in human plasma. Regul. Pept. 7, 335-345
116. 116 Sudoh, T., Maekawa, K., Kojima, M., Minamino, N., Kangawa, K. and Matsuo, H. (1989) Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem. Biophys. Res. Commun. 159, 1427-1434
117. 117 Laudano, A. P. and Doolittle, R. F. (1980) Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry 19, 1013-1019
118. 118 Poulsen, K., Burton, J. and Haber, E. (1973) Competitive inhibitors of renin. Biochemistry 12, 3877-3882
119. 119 Duke Cohan, J. S., Morimoto, C., Rocker, J. A. and Schlossman, S. F. (1995) A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26). J. Biol. Chem. 270, 14107-14114
120. 120 Iwaki Egawa, S., Watanabe, Y. and Pujimoto, Y. (1993) N-terminal amino acid sequence of the 60-kDa protein of rat kidney dipeptidyl peptidase IV. Biol. Chem. Hoppe Seyler 374, 973-975
121. 121 Underwood, R., Chiravuri, M., Lee, H. et al. (1999) Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J. Biol. Chem. 274, 34053-34058
122. 122 Shneider, B. L., Thevananther, S., Moyer, M. S. et al. (1997) Cloning and characterization of a novel peptidase from rat and human ileum. J. Biol. Chem. 272, 31006-31015
123. 123 Pangalos, M. N., Neefs, J. M., Somers, M. et al. (1999) Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity. J. Biol. Chem. 274, 8470-8483
124. 124 Blanco, J., Jacotot, E., Callebaut, C., Krust, B. and Hovanessian, A. G. (1997) Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity. Adv. Exp. Med. Biol. 421, 193-199
125. 125 Blanco, J., Nguyen, C., Callebaut, C. et al. (1998) Dipeptidyl-peptidase IV-beta-further characterization and comparison to dipeptidyl-peptidase IV activity of CD26. Eur. J. Biochem. 256, 369-378
126. 126 Levy, E. M., Borrelli, D. J., Mirin, S. M. et al. (1991) Biological measures and cellular immunological function in depressed psychiatric inpatients. Psychiatry Res. 36, 157-167
127. 127 Lautenbacher, S., Roscher, S., Strian, D., Fassbender, K., Krumrey, K. and Krieg, J. C. (1994) Pain perception in depression: relationships to symptomatology and naloxone-sensitive mechanisms. Psychosom. Med. 56, 345-352
128. 128 Christensen, L. and Somers, S. (1994) Adequacy of the dietary intake of depressed individuals. J. Am. Coll. Nutr. 13, 597-600